1. Home
  2. FUN vs PVLA Comparison

FUN vs PVLA Comparison

Compare FUN & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cedar Fair L.P.

FUN

Cedar Fair L.P.

BUY

Current Price

$8.36

Market Cap

1.9B

ML Signal

BUY

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

HOLD

Current Price

$122.65

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FUN
PVLA
Founded
1983
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.9B
IPO Year
2023
2013

Fundamental Metrics

Financial Performance
Metric
FUN
PVLA
Price
$8.36
$122.65
Analyst Decision
Buy
Strong Buy
Analyst Count
14
16
Target Price
$19.69
★ $231.25
AVG Volume (30 Days)
★ 3.8M
192.5K
Earning Date
11-05-2026
11-10-2026
Dividend Yield
★ 14.80%
N/A
EPS Growth
N/A
★ 52.62
EPS
N/A
★ N/A
Revenue
★ $3,100,289,000.00
$42,810,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.64
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
14.45
★ 65.28
52 Week Low
$7.95
$68.96
52 Week High
$27.37
$161.38

Technical Indicators

Market Signals
Indicator
FUN
PVLA
Relative Strength Index (RSI) 26.96 37.86
Support Level N/A $120.61
Resistance Level $18.13 $136.35
Average True Range (ATR) 0.69 7.26
MACD -0.23 -0.98
Stochastic Oscillator 9.90 21.87

Price Performance

Historical Comparison
FUN
PVLA

About FUN Cedar Fair L.P.

Six Flags Entertainment Corp is North America's regional amusement resort operator with approximately 27 amusement parks, around 15 separately gated water parks, and nine resort properties across the U.S., Canada, and Mexico. It provides coasters, themed rides, thrilling water parks, resorts, and a portfolio of beloved intellectual properties such as Looney Tunes, DC Comics, and PEANUTS. The parks are family-oriented, with recreational facilities for people of all ages, and provide clean and attractive environments with exciting rides and immersive entertainment. The Company generates revenue from sales of admission to the amusement parks and water parks, from purchases of food, merchandise and games both inside and outside the parks, from the sale of accommodations and other extra-charge.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.

Share on Social Networks: